Colgate-Palmolive: stocks, financial statements

Disable ads for free
Dividends News
Favorites

An American company that produces personal care products: soap, oral care products, toothpastes and brushes. It acquired its current name in 1956. The corporation belongs to the category of FMCG-companies that produce consumer fast-use products. Its product range also includes pet food, veterinary drugs, and household chemicals. The corporation has branches and offices in more than 200 countries and owns the rights to the well-known brands Colgate, Palmolive, Mennen, Lady Speed Stick, Softsoap, Protex, Sorriso, etc.

The company has a large number of subsidiaries, but only two of them are officially registered - in the United States and India. In 2004, it began a restructuring process, phasing out some products. During this period, new factories for the production of toothpaste were built in the United States, Mexico and Poland.

The company owns two research centers in new Jersey and Kansas. Their functions are divided: the first is responsible for the development of new personal hygiene products, and the second - animal feed.

  • CL Ticker
  • NYSE Exchange
  • 34,500 Employees
17 rated
  • $82.18, $-0.13 (-0.16%) Previous Close
  • 2,263,698 Previous Volume
  • $64.08 / $85.45 52 week low / high
  • -3.83% Percent off 52 week high
  • 2021-05-07 Updated
  • 2.14% Dividend Yield (trailing)
  • 2.19% Dividend Yield (forward)
  • 0 Public float
  • 845,968,780 Outstanding shares
  • 26.13 P/E
  • 69.52 B Market Cap
Disable ads for free

Financial statements — Colgate-Palmolive

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
16B 16B 16B 15B 15B
Cost Of Revenue
6.5B 6.4B 6.3B 6.2B 6.1B
Gross Profit
10B 9.3B 9.2B 9.3B 9.1B
Research and Development
0 0 0 0 0
Selling General and Admin
6B 5.6B 5.4B 5.5B 5.2B
Operating Expense
13B 12B 12B 12B 11B
Operating Income
3.9B 3.7B 3.8B 3.8B 3.8B
Other Income Expense Net
0 0 0 0 0
EBIT
3.9B 3.7B 3.8B 3.8B 3.9B
Interest Income
160M 150M 140M 100M 99M
Pretax Income
3.6B 3.3B 3.5B 3.5B 3.7B
Income Tax
790M 770M 910M 1.3B 1.2B
Minority Interest
170M 160M 160M 150M 150M
Net Income
2.7B 2.4B 2.4B 2B 2.4B
Net Income Basic
2.7B 2.4B 2.4B 2B 2.4B
20 ← 16 2020 2019 2018 2017 2016
Current cash
890M 910M 740M 1.5B 1.3B
Short term investments
510M 430M 410M 390M 420M
Receivables
1.3B 1.4B 1.4B 1.5B 1.4B
Inventory
1.7B 1.4B 1.3B 1.2B 1.2B
Other current assets
510M 430M 410M 390M 420M
Current assets
4.3B 4.2B 3.8B 4.6B 4.3B
Long term investments
12B 11B 8.4B 8B 7.8B
Property plant equipment
3.7B 3.8B 3.9B 4.1B 3.8B
Goodwill
3.8B 3.5B 2.5B 2.2B 2.1B
Intangible assets
2.9B 2.7B 1.6B 1.3B 1.3B
Other assets
860M 750M 170M 220M 220M
Total assets
16B 15B 12B 13B 12B
Accounts payable
1.4B 1.2B 1.2B 1.2B 1.1B
Current long term debt
270M 510M 12M 11M 13M
Other current liabilities
2.7B 2.3B 2.1B 2.2B 2.2B
Total current liabilities
4.4B 4B 3.3B 3.4B 3.3B
Long term debt
7.3B 7.3B 6.4B 6.6B 6.5B
Other liabilities
2.2B 2.1B 2B 2.3B 2B
Minority Interest
360M 440M 300M 300M 260M
Total Liabilities
15B 15B 12B 13B 12B
Common stock
860M 860M 870M 880M 890M
Retained earning
24B 23B 22B 21B 20B
Treasury stock
-23B -22B -21B -20B -19B
Capital surplus
Shareholder equity
740M 120M -100M -60M -240M
Net tangible assets
-6B -6.1B -4.3B -3.6B -3.7B
20 ← 16 2020 2019 2018 2017 2016
Net Income
2.7B 2.4B 2.4B 2B 2.4B
Depreciation
540M 520M 510M 480M 440M
Changes in receivables
-180M 40M -80M 69M -16M
Changes in inventories
270M 150M 29M 50M -9M
Cash change
-18M 170M -810M 210M 310M
Cash flow
3.7B 3.1B 3.1B 3.1B 3.1B
Capital expenditures
-410M -340M -440M -550M -590M
Investments
Investing activity other
Total investing cash flows
-780M -2.1B -1.2B -470M -500M
Dividends paid
Net borrowings
6.2B 6.5B 5.2B 4.6B 4.8B
Other financing cash flows
Cash flow financing
-2.9B -870M -2.7B -2.5B -2.2B
Exchange rate effect
Disable ads for free
Disable ads for free